Australasian Neuromuscular Network - ANN

Australasian Neuromuscular Network - ANN

The Australasian Neuromuscular Network (ANN) is committed to establishing a cohesive, integrated neuromuscular network that enables people to work together across Australia and New Zealand for the well-being of patients. We will provide a forum to advance and disseminate information, be a single voice to advocate for patients and guide best practice in diagnosis, care and treatment. Patients will benefit considerably from access to clinical trials (via international partners such as TREAT-NMD), new gene discoveries, improved diagnosis and new therapies through coordinated excellence of care.

The ANN is structured to address issues relating to clinical care and research effort. Each area has a Steering Committee comprising individuals with expertise in each area, as well as providing representation of all major groups active in the care and study of individuals with neuromuscular disorders across Australia and New Zealand.

Given the rare nature of the disorders, and that patients are located all over Australia and throughout New Zealand, a collaborative network to address diagnosis, prevention and treatment is extremely important. The recently established Australasian Neuromuscular Network (ANN), involving doctors, medical professionals, scientists and representatives from advocacy groups will ensure that the best evidence from our clinical and laboratory based research is quickly translated into best clinical practice.




Kathy  North Kathy North

Professor Kathryn North was appointed as Director of the Murdoch Childrens Research Institute, Director of the Victoria Clinical Genetics Service and the David Danks Professor of Child Health Research at the University of Melbourne in February 2013.

More Info